TL;DR:PillEye captures the pharmacy workflow market by replacing manual counting with camera-based automation, yet its transition to a high-cost subscription model creates a significant churn risk that threatens its professional-grade utility. Users feel Frustrated, praising high accuracy in counting large volumes of tablets during live photo mode sessions but frustrated by aggressive subscription pricing model creates significant friction for professional and casual users alike. PillEye provides industry-leading counting accuracy, but the aggressive subscription model and network dependency alienate professional users, so the PM must prioritize offline functionality and flexible pricing to stabilize retention..|TL;DR:PillEye captures the pharmacy workflow market by replacing manual counting with camera-based automation, yet its transition to a high-cost subscription model creates a significant churn risk that threatens its professional-grade utility. Users feel Frustrated, praising high accuracy in counting large volumes of tablets during live photo mode sessions but frustrated by aggressive subscription pricing model creates significant friction for professional and casual users alike. PillEye provides industry-leading counting accuracy, but the aggressive subscription model and network dependency alienate professional users, so the PM must prioritize offline functionality and flexible pricing to stabilize retention..

PillEye – tablet, pill counter is a challenged medical app that is free with in-app purchases. With a 3.7/5 rating from 1.8K reviews, it faces significant user friction. Users particularly appreciate high accuracy in counting large volumes of tablets during live photo mode sessions, though aggressive subscription pricing model creates significant friction for professional and casual users alike remains a common concern.

What is PillEye – tablet, pill counter?

PillEye is a medical utility app for pharmacists and veterinarians that automates pill counting via camera recognition on iOS and Android.

Users hire PillEye to eliminate manual labor in inventory management, but the current subscription-first design forces a trade-off between professional efficiency and recurring cost.

Current Momentum

v3.12 · 1mo ago

Active
  • Shipped Prism Mode for tablet users.
  • Upgraded AI engine for object recognition.
  • Added timer to prism-mode interface.
AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Active Nemesis

Fragmented niche

No dominant direct rival identified yet — see Other Rivals below.

Other Rivals

Medisafe Medication Management
GoodRx: Prescription Savings
NimbleRx
Doximity

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Live ModeDifferentiator

Real-time pill counting via camera feed, supporting up to 1,000 pills simultaneously.

Photo ModeStandard

Static image capture to count up to 500 pills with 99.99% accuracy.

Prism ModeDifferentiator

Tablet-only feature using a hardware prism attachment to monitor counting while viewing the screen.

How much does it cost?

Freemium
  • Free version available
  • In-app purchases offered

Freemium model utilizing in-app purchases to monetize professional pharmacy workflow tools.

Who Built It?

Medility Inc. app icon

Equipping healthcare professionals with Vision AI tools to automate manual pill counting and improve pharmacy inventory accuracy.

Portfolio

2

Apps

Free 1
Medical100%

Who is Medility?

Medility has established a specialized position in pharmacy automation by digitizing manual counting workflows through computer vision. Their moat is the high-precision requirement of medical-grade object detection, which serves as a barrier against general-purpose scanning utilities. The recent introduction of BatchEye indicates a strategic shift toward high-volume inventory management for veterinary and clinical environments, moving the portfolio beyond individual prescription fulfillment.

Who is Medility for?

  • Pharmacists
  • Pharmacy technicians
  • Veterinarians requiring high-accuracy inventory
  • Prescription counting tools
Active

Portfolio momentum

Maintains an active development cycle with 7 releases in the last 6 months, including the launch of a second specialized utility in early 2025.

Last release · 54d agoActive apps · 1

What other apps does Medility make?

What do users think recently?

High confidence · 49 reviews analyzed

How did the latest release land?

Overall
3.7/ 5
(1.8K)
Current version
2.9/ 5
-0.8 vs overall
(217)
Main signal post-update: aggressive subscription pricing model creates significant friction for professional and casual users alike.

What is the recent mood?

Frustrated

Recent user voice shows a frustrated sentiment. Users appreciate high accuracy in counting large volumes of tablets during live photo mode sessions, but report aggressive subscription pricing model creates significant friction for professional and casual users alike.

Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.

What is the competitive landscape for PillEye – tablet, pill counter?

How's The Medical Market?

**Pricing Strategy**: Freemium model with in-app purchases for professional tools. **Target Audience**: Pharmacists, pharmacy technicians, veterinarians, and healthcare professionals. **Performance**: PillEye holds a #14 Grossing position in the US Medical category, but the Grossing rank lags behind the Free chart entry, signaling monetization friction.

How does it evolve in the Medical market?

PillEye holds a #14 Grossing position in the US Medical category, but the Grossing rank lags behind the Free chart entry, signaling monetization friction relative to its discovery advantage.

ChartRankChange
AndroidGrossing#233
iOSGrossing#486

The rivals identified

Peers

Provides comprehensive medication adherence tracking and reminders which PillEye lacks entirely in its current feature set.

Integrates with pharmacy databases to provide automated refill alerts and medication interaction warnings for patients.

Leverages a massive network of pharmacy pricing data to drive user acquisition through direct cost-saving utility.

Maintains high-frequency release cycles to optimize the prescription search and coupon redemption experience for users.

New Kids on the Block

Focuses on end-to-end digital pharmacy fulfillment, shifting the user journey from counting pills to home delivery.

Integrates real-time delivery tracking and pharmacy communication directly into the patient's mobile experience.

Doximity

Doximity

4.8 (191.5K)

Doximity

High release frequency indicates a strong commitment to maintaining a professional-grade medical communication platform.

Provides a secure, HIPAA-compliant communication layer for healthcare professionals that PillEye does not currently offer.

Acts as a professional network hub, creating a sticky ecosystem for clinicians that transcends simple utility tools.

The outtake for PillEye – tablet, pill counter

Strengths to defend, gaps to attack

Core Strengths

  • 99.99% accuracy in object recognition
  • Prism Mode creates B2B equipment moat
  • Multi-user logs support audit trails

Critical Frictions

  • Subscription cost above category median
  • Mandatory network dependency for counting
  • 0.86-star Android-iOS rating gap

Growth Levers

  • Offline-mode for clinical environments
  • B2B partnerships with pharmacy systems
  • Lifetime license tiers to reduce churn

Market Threats

  • Rapid development pace of NimbleRx
  • Doximity professional network stickiness
  • Negative sentiment driving manual alternatives

What are the next best moves?

highInvest

Ship offline-capable counting because mandatory network dependency is a top complaint → restore clinical usability

Users report verification code failures and network dependency hinder clinical workflows.

Trade-off: Push the Prism Mode expansion to Q3 — offline reliability is a higher churn risk.

highPivot

Pivot to a lifetime license tier because subscription pricing is the #1 complaint → reduce churn

Sentiment analysis shows users are willing to pay for utility if the pricing structure is reasonable.

Trade-off: Pause the annual subscription price-test — lifetime license conversion has higher revenue impact.

A counter-intuitive read

The high subscription price is not just a monetization error, it is a strategic misread of the pharmacy market where free, reliable, offline-capable tools are the primary barrier to entry.

Feature Gaps vs Competitors

  • Medication adherence tracking (available in Medisafe but missing here)
  • Automated refill alerts (available in Medisafe but missing here)

Key Takeaways

  • Prioritize offline-capable counting to restore trust with clinical users.
  • Re-evaluate the subscription pricing tier to prevent mass churn.
  • Leverage Prism Mode as a B2B entry point for pharmacy chains.

PillEye provides industry-leading counting accuracy, but the aggressive subscription model and network dependency alienate professional users, so the PM must prioritize offline functionality and flexible pricing to stabilize retention.

Where Is It Heading?

Declining

The pharmacy utility market is shifting toward integrated fulfillment and adherence, leaving PillEye's standalone counting tool exposed to churn. The current monetization strategy is the primary driver of negative sentiment, so the PM must pivot to a more flexible pricing model to prevent long-term user attrition.

The transition to a subscription-first model drives high churn, which compounds the negative sentiment trend visible in recent reviews.

Recent updates focus on tablet-specific hardware features, but fail to address the core stability and login complaints from professional users.

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by PillEye – tablet, pill counter, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

The app has pivoted to a high-cost subscription model, triggering negative sentiment and churn, while simultaneously refining its feature set to focus on hardware-integrated counting.

shifted

Subscription-first monetization

declined

Negative sentiment trend

improved

Live Mode repositioning

added

New operational weaknesses

Cite this report

Marlvel.ai. “PillEye – tablet, pill counter Intelligence Report.” Updated Jun 9, 2026. https://marlvel.ai/intel-report/medical/com-rocateer-mediscount

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0